TheraCann Adds Blockchain Functionality to ETCH biotrace Platform Powered by Applied DNA
June 24 2019 - 8:05AM
Business Wire
ETCH biotrace to Combine Applied DNA’s DNA
tag-based Forensic Traceability and Authenticity with TruTrace's
Industry Blockchain Hub to Deliver Unparalleled Tag-Test-Track
Capabilities to Global Cannabis and Hemp Industry
Applied DNA Sciences, Inc. (“Applied DNA”, NASDAQ: APDN),
announced today that its cannabis and hemp industry partner,
TheraCann International Benchmark Corporation (“TheraCann”), a
leading full service international cannabis consultancy and
technology firm, has signed a letter of intent (LOI) with TruTrace
Technologies (CSE: TTT) (OTC: BKKSF) (“TruTrace”), creator of the a
fully-integrated blockchain platform that registers and tracks
intellectual property for the cannabis industry.
The CertainT physical molecular taggant, backed up by Applied
DNA’s in-field and laboratory authentication products and services,
can provide unique traceability information for the product itself
not available elsewhere. The collaboration includes connecting
TruTrace’s StrainSecure™ system and blockchain with TheraCann’s
non-appendable Electronic Product Code Information Services (EPCIS)
blockchain to provide forensic levels of traceability of cannabis
and cannabis derivatives at any point in the supply chain to
guarantee product quality.
“The ETCH biotrace system provides seed-to-sale traceability for
cannabis and hemp and uses Applied DNA’s unique, safe and
persistent molecular tag for the identification of any biomass,
extraction, isolate, derivative or cannabis packaging. The
molecular tag does not genetically modify the organism (non-GMO)
and can be added into derivative products within the supply chain,”
said Jason Warnock, Chief Executive Officer of TheraCann.
“Collaborating with TruTrace connects the dots with an information
platform linking the provenance of material, testing information
and patient data that is so vital to the safety and efficacy of the
global market.”
About CertainT
Applied DNA’s CertainT® “Tag-Test-Track” platform, enables
companies and their supply chains to designate a unique molecular
identity Tag that has meaning specific to the tagged material: for
example, geographic facility location, brand, product line or even
date of manufacture. This Tag can be blended into excipients,
active ingredients and packaging inks and varnishes in the
pharmaceutical, nutraceutical, and dietary supplements industry.
The Tags are then Tested either in the field or in the lab,
depending on application requirements.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping and pre-clinical nucleic acid-based
therapeutic drug candidates.
Applied DNA makes life real and safe by providing innovative,
molecular-based technology solutions and services that can help
protect products, brands, entire supply chains, and intellectual
property of companies, governments and consumers from theft,
counterfeiting, fraud and diversion.
Visit adnas.com for more information. Follow us on Twitter and
LinkedIn. Join our mailing list.
Common stock listed on NASDAQ under the symbol APDN, and
warrants are listed under the symbol APDNW.
Forward-Looking Statements
The statements made by Applied DNA in this press release may be
“forward-looking” in nature within the meaning of the Private
Securities Litigation Act of 1995. Forward-looking statements
describe Applied DNA’s future plans, projections, strategies and
expectations, and are based on assumptions and involve a number of
risks and uncertainties, many of which are beyond the control of
Applied DNA. Actual results could differ materially from those
projected due to its history of net losses, limited financial
resources, limited market acceptance, ability to maintain its
NASDAQ listing and various other factors detailed from time to time
in Applied DNA’s SEC reports and filings, including our Annual
Report on Form 10-K filed on December 18, 2018 and our subsequent
quarterly reports on Form 10-Q filed on February 7, 2019 and May 9,
2019, and other reports we file with the SEC, which are available
at www.sec.gov. Applied DNA undertakes no obligation to update
publicly any forward-looking statements to reflect new information,
events or circumstances after the date hereof to reflect the
occurrence of unanticipated events, unless otherwise required by
law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190624005195/en/
investor contact: Sanjay M. Hurry, LHA Investor
Relations, 212-838-3777, shurry@lhai.com program contacts:
Judy Murrah, Chief Information Officer, judy.murrah@adnas.com
web: www.adnas.com twitter: @APDN
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2023 to Apr 2024